Intracellular calcium chelator BAPTA protects cells against toxic calcium overload but also alters physiological calcium responses

Cell Calcium

Volumn 21, Issue 6, 1997, Pages 453-459

  Collatz, M B ^a   Rudel R ^a   Brinkmeier, H ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHELATING AGENT; CALCIUM ION; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FURA 2; IONOMYCIN; POTASSIUM CHLORIDE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL DAMAGE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOTOXICITY; GLIOMA; HYBRID CELL; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0030747259     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4160(97)90056-7     Document Type: Article

References (30)

1. Nicotera P., Bellomo G., Orrenius S. Calcium-mediated mechanisms in chemically induced cell death. Annu Rev Pharmacol Toxicol 1992; 32: 449-470.
2. Eimerl S., Schramm M. The quantity of calcium that appears to induce neuronal death. J Neurochem 1994; 62: 1223-1226.
3. Orrenius S., Nicotera P. The calcium ion and cell death. J Neural Transm Suppl 1995; 43: 1-11.
4. 2+ elevation induced by in vitro ischemia-like condition in hippocampal slices. Brain Res 1993; 601: 103-110.
5. Rataud J., Debarnot E, Mary V., Pratt J., Stutzmann J-M. Comparative study of voltage-sensitive sodium channel blockers in focal ischaemia and electrical convulsions in rodents. Neurosci Lett 1994; 172: 19-23.
6. Xie Y., Dengler K., Zacharias E., Wilffert B., Tegtmeier F. Effects of the sodium channel blocker tetrodotoxin (TTX) on cellular ion homeostasis in rat brain subjected to complete ischemia. Brain Res 1994; 652: 216-224.
7. Martin R.L., Lloyd H.G.E., Cowan A.I. The early events of oxygen and glucose deprivation: setting the scene for neuronal death? Trends Neurosci 1994; 6: 251-257
8. Koroshetz W.A., Moskowitz M.A. Emerging treatments for stroke in humans. Trends Pharmacol Sci 1996; 17: 227-233.
9. Saito K-I., Elce J.S., Hamos J.E., Nixon R.A. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain of Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 1993; 90: 2628-2632.
10. 2 activation and . neuronal injury. Ann NY Acad Sci 1993; 679: 110-120.
11. Appel S.H., Stefani E. Amyotrophic lateral sclerosis: etiology and pathogenesis. In: Appel S.H. (ed) Current Neurology, vol. 11. Chicago: Year Book, 1991; 287-310.
12. Eisen A. Amyotrophic lateral sclerosis as a multifactorial disease. Muscle Nerve 1995; 18: 741-752.
13. 2+ and protein kinase C. Trends Pharmacol Sci 1996; 17: 114-120.
14. 2+ currents in a motoneuron cell line. Ann Neurol 1995; 37: 102-109.
15. Elliot J.L., Snider W.D. Parvalbumin is a marker of ALS-resistant motor neurons. Neuroreport 1995; 6: 449-452.
16. Reiner A., Medina L., Figueredo-Cardenas G., Anfinson S. Brainstem motoneuron pools that are selectively resistant in amyotrophic lateral sclerosis are preferentially enriched in parvalbumin: evidence from monkey brainstem for a calcium-mediated mechanism in sporadic ALS. Exp Neurol 1995; 131: 239-250.
17. Ince P., Stout N., Shaw P. et al. Parvalbumin and calbindin D-28K in the human motor system and in motor neuron disease. Neuropathol Appl Neurobiol 1993; 19: 291-299.
18. Nishiyama E., Ohwada J., Iwamoto N., Arai H. Selective loss of calbindin D28K-immunoreactive neurons in the cortical layer II in brains of Alzheimer's disease: a morphometric study. Neurosci Lett 1996; 163: 223-226.
19. 28k expression in transfected mouse NIH3T3 cells. Cell Calcium 1993; 14: 349-358.
20. i and glutamate neurotoxicity in vitro. J Neurophysiol 1994; 72: 1973-1992.
21. 2+ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivo. Neuron 1993; 11: 221-235.
22. Rahn K., Brinkmeier H., Rudel R. Human serum albumin enhances sodium currents in NH15-CA2 neuroblastoma × glioma hybrid cells. Neurosci Lett 1995; 194: 25-28.
23. 2+ levels. Cell Calcium 1996; 19: 383-390.
24. Reiser G., Hamprecht B. Differential effects of various cAMP derivatives on the morphological and electrical maturation of neuroblastoma × glioma hybrid cells. Exp Cell Res 1982; 141: 498-503.
25. Hamprecht B., Glaser T., Reiser G., Bayer E., Probst F. Culture characteristics of hormone-responsive neuroblastoma × glioma hybrid cells. Methods Enzymol 1985; 109: 316-341.
26. Hamm S., Rüdel R., Brinkmeier H. Effects of interleukln-2 and interleukin-1β on neuronal sodium channels. Pflügers Arch 1997; In press.
27. Föhr K.J., Wardid W., Gratzl M. Calculation and control of free divalent cation in solutions used for membrane fusion studies. Methods Enzymol 1993; 221: 149-157
28. 2+ concentrations are not elevated at rest in cultured muscle from Duchenne (DMD) patients and in MDX mouse muscle fibers. Pflügers Arch 1994; 426: 499-505.
29. Narahashi T., Herman M.D. Overview of toxins and drugs as tools to study excitable membrane ion channels: I. Voltage-activated channels. Methods Enzymol 1992; 207: 620-643.
30. Collatz M.B., Rüdel R., Brinkmeier H. Intracellular calcium transients in neuroblastoma cells and their modification by the calcium-chelator BAPTA/AM. J Muscle Cell Motil 1996; 17: 378.